VRTX
#125
Vertex Pharmaceuticals Incorporated - Common Stock
480.2 5 USD
-0.01%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-1.06%
Variación mensual
+7.94%
Variación en los últimos 6 meses
+7.01%
Cambio anual
+1.53%
Cierres anteriores
485.3 9
Open
480.2 5
Mínimo
480.2 5
High
480.2 5
Volumen
507
Financials
- Market Capitalization 121.89 B
- Employee 6 400
- Founded 1989
- CEO Reshma Kewalramani
- Website www.vrtx.com
- Headquarter Massachusetts, United States
- FIGI BBG000C1S2X2
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
29.59
Relación precio/flujo de caja
9.75
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 238 |  REGN Regeneron Pharmaceuticals, Inc. - Common Stock | 663.09 USD | -0.22% | -0.01% | +8.11% | +15.81% | 69.52 B USD | ||
| 295 |  ARGX argenx SE - American Depositary Shares | 876.25 USD | -0.16% | -5.71% | -1.84% | +54.53% | 54.23 B USD | ||
| 378 |  RVMD Revolution Medicines, Inc. - Common Stock | 183.95 USD | -1.57% | -3.13% | +18.68% | +232.04% | 39.11 B USD | ||
| 386 |  ALNY Alnylam Pharmaceuticals, Inc. - Common Stock | 288.06 USD | -3.58% | -8.97% | +1.82% | -9.10% | 38.46 B USD |